JP2005508959A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508959A5
JP2005508959A5 JP2003535782A JP2003535782A JP2005508959A5 JP 2005508959 A5 JP2005508959 A5 JP 2005508959A5 JP 2003535782 A JP2003535782 A JP 2003535782A JP 2003535782 A JP2003535782 A JP 2003535782A JP 2005508959 A5 JP2005508959 A5 JP 2005508959A5
Authority
JP
Japan
Prior art keywords
mycophenolic acid
tablet
enteric
mycophenolate
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003535782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508959A (ja
Filing date
Publication date
Priority claimed from GBGB0124953.1A external-priority patent/GB0124953D0/en
Application filed filed Critical
Publication of JP2005508959A publication Critical patent/JP2005508959A/ja
Publication of JP2005508959A5 publication Critical patent/JP2005508959A5/ja
Pending legal-status Critical Current

Links

JP2003535782A 2001-10-17 2002-10-16 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物 Pending JP2005508959A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0124953.1 2001-10-17
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds
PCT/EP2002/011589 WO2003032978A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009012781A Division JP2009137996A (ja) 2001-10-17 2009-01-23 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物

Publications (2)

Publication Number Publication Date
JP2005508959A JP2005508959A (ja) 2005-04-07
JP2005508959A5 true JP2005508959A5 (enExample) 2005-12-22

Family

ID=9924043

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003535782A Pending JP2005508959A (ja) 2001-10-17 2002-10-16 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物
JP2009012781A Pending JP2009137996A (ja) 2001-10-17 2009-01-23 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009012781A Pending JP2009137996A (ja) 2001-10-17 2009-01-23 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物

Country Status (31)

Country Link
US (3) US20050013859A1 (enExample)
EP (1) EP1438040B2 (enExample)
JP (2) JP2005508959A (enExample)
KR (1) KR100671367B1 (enExample)
CN (1) CN1310640C (enExample)
AR (2) AR036813A1 (enExample)
AT (1) ATE374023T1 (enExample)
AU (1) AU2002338897B2 (enExample)
BR (1) BR0213355A (enExample)
CA (1) CA2460574A1 (enExample)
CO (1) CO5390076A1 (enExample)
CY (1) CY1107841T1 (enExample)
DE (1) DE60222687T3 (enExample)
DK (1) DK1438040T4 (enExample)
EC (2) ECSP024342A (enExample)
ES (1) ES2292819T5 (enExample)
GB (1) GB0124953D0 (enExample)
HU (1) HU231114B1 (enExample)
IL (2) IL160968A0 (enExample)
MX (1) MXPA04003636A (enExample)
MY (1) MY139206A (enExample)
NO (1) NO341804B1 (enExample)
NZ (1) NZ532280A (enExample)
PE (1) PE20030476A1 (enExample)
PL (2) PL234541B1 (enExample)
PT (1) PT1438040E (enExample)
RU (2) RU2338528C2 (enExample)
SI (1) SI1438040T2 (enExample)
TW (1) TWI333861B (enExample)
WO (1) WO2003032978A1 (enExample)
ZA (1) ZA200401977B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
CN101052631A (zh) * 2004-07-20 2007-10-10 特瓦药厂私人有限公司 结晶霉酚酸钠
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
WO2006086498A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
WO2006086500A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Compositions and methods for treating vascular, autoimmune and inflammatory diseases
EP1940388A2 (en) * 2005-09-30 2008-07-09 Novartis AG Dpp iv inhibtor for use in the treatment of autoimmune diseases and graft rejection
EP1965760B1 (de) 2005-12-21 2013-02-27 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
CA2640283A1 (en) * 2006-02-13 2007-08-23 Novartis Ag High dosage of mycophenolic acid (mpa)
WO2008148742A2 (de) 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US8568780B2 (en) 2007-06-06 2013-10-29 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
MX2010001711A (es) * 2007-08-13 2010-03-11 Panacea Biotec Ltd Composiciones de liberacion extendida que comprenden micofenolato sodico y procedimientos de las mismas.
AU2009220779A1 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
US20100010082A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011046546A1 (en) * 2009-10-13 2011-04-21 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
JP7385474B2 (ja) * 2017-03-13 2023-11-22 オカヴァ ファーマシューティカルズ， インコーポレイテッド 非ヒト哺乳動物にミコフェノール酸活性剤を送達すための方法および組成物
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
WO2019238647A1 (en) * 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
EP4438037A1 (en) * 2021-01-28 2024-10-02 Priothera SAS Methods of treatment with s1p receptor modulators
EP4346790A4 (en) * 2021-05-26 2025-04-16 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
AU3178293A (en) * 1992-11-24 1994-06-22 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
DK0686034T3 (da) * 1993-02-26 2001-08-27 Procter & Gamble Bisacodyl-doseringsform
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
ES2248793T3 (es) * 1993-10-01 2006-03-16 Roche Palo Alto Llc Suspensiones orales de alta dosis de mofetil micofenolato.
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
WO2000067773A2 (en) * 1999-05-10 2000-11-16 Novartis Ag Combinations of immunosupressive agents for the treatment or prevention of graft rejections
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
EP1259631B1 (en) * 2000-02-29 2005-10-12 Biocon Limited Manufacture and purification of mycophenolic acid
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2005508959A5 (enExample)
CA2348086C (en) Controlled-release pharmaceutical formulations
KR101563390B1 (ko) 감마-하이드록시부티르산을 주성분으로 하는 신규 조성물
RU2004115332A (ru) Фармацевтические композиции, содержащие микрофенольную кислоту или соль (микофенолят)
FI92904C (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
JP2009545560A5 (enExample)
JP2007506766A5 (enExample)
EA023532B1 (ru) Флотирующие микрогранулы
RU99126869A (ru) Фармацевтический препарат омепразола
UA69396C2 (uk) ПЕРОРАЛЬНА ДОЗОВАНА ФАРМАЦЕВТИЧНА ФОРМА З ДИСКРЕТНИМ ВИВІЛЬНЕННЯМ ІНГІБІТОРА Н<sup>+</sup>,К<sup>+</sup>,-АТФ-АЗИ (ВАРІАНТИ) ТА СПОСІБ ЇЇ ОДЕРЖАННЯ (ВАРІАНТИ) І СПОСІБ ЛІКУВАННЯ (ВАРІАНТИ)
CA2670690C (en) Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid
RU2008106220A (ru) Гастроретентивные композиции и способ их изготовления
RU2006139000A (ru) Диспергирующиеся таблетки деферасирокса
ITMI941262A1 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
KR20130103384A (ko) 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
CN101804030A (zh) 一种双氯芬酸钠微丸制剂及其制备方法
CA2461576A1 (en) Process for the preparation of tablets comprising s-adenosylmethionine
JP3836528B2 (ja) イブプロフェン含有錠剤及びその製造法
US20110280945A1 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
JPH05255088A (ja) 抗潰瘍剤含有製剤
JPH0733659A (ja) 抗潰瘍剤含有製剤
JP2002518334A5 (enExample)
WO2013095316A1 (en) Synergic combination comprising anti-diabetic agent
WO2003094899A1 (es) Nuevo procedimiento para la preparacion de composiciones de liberacion programada conteniendo (s) -1- [n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline, y al producto obtenido por dicho procedimiento
JP2004535417A5 (enExample)